Literature DB >> 2525911

CD23: a multi-functional receptor/lymphokine?

J Gordon, L Flores-Romo, J A Cairns, M J Millsum, P J Lane, G D Johnson, I C MacLennan.   

Abstract

With the demonstration of identity between CD23 and the low affinity IgE Fc receptor (Fc epsilon RII), two previously separate avenues of immunological research have converged into one. Particularly in its guise as 'Blast-2' antigen, evidence has been mounting to implicate CD23 as an important molecule in B-cell growth regulation. It might seem pertinent, however, to question a role for an apparently isotype-specific immunoglobulin (Ig) receptor in general B-cell processes. In this article, John Gordon and colleagues attempt to reconcile the two, currently diverse, schools of thought regarding the primary function of CD23 and to provide a structural model that accounts for the biological pleiotropy observed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2525911     DOI: 10.1016/0167-5699(89)90171-0

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  42 in total

1.  Partial characterization of natural and recombinant human soluble CD23.

Authors:  K Rose; G Turcatti; P Graber; S Pochon; P O Regamey; K U Jansen; E Magnenat; N Aubonney; J Y Bonnefoy
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

Review 2.  Microbial pathogenicity and host defense in burned patients--the role of inflammatory mediators.

Authors:  W König; B Schlüter; J Scheffer; M Köller
Journal:  Infection       Date:  1992       Impact factor: 3.553

Review 3.  CD23/FcεRII: molecular multi-tasking.

Authors:  M Acharya; G Borland; A L Edkins; L M Maclellan; J Matheson; B W Ozanne; W Cushley
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

4.  Elevated soluble CD23 levels in the sera from patients with localized scleroderma.

Authors:  S Sato; M Fujimoto; K Kikuchi; H Ihn; K Tamaki; K Takehara
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

5.  Immunohistochemical demonstration of CD23 expression on lymphocytes in rheumatoid synovitis.

Authors:  E A Hellen; D C Rowlands; T T Hansel; G D Kitas; J Crocker
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

6.  Detection of circulating Fc epsilon R2/CD23+ monocytes in patients with rheumatic diseases.

Authors:  H Becker; P Potyka; C Weber; K Federlin
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

7.  Invasin of Yersinia pseudotuberculosis activates human peripheral B cells.

Authors:  E Lundgren; N Carballeira; R Vazquez; E Dubinina; H Bränden; H Persson; H Wolf-Watz
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

Review 8.  Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection.

Authors:  J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

Review 9.  [Application of humanized Anti-IgE antibodies (omalizumab). A new principle in the treatment of allergic diseases in ENT medicine].

Authors:  O Pfaar; L Klimek
Journal:  HNO       Date:  2007-12       Impact factor: 1.284

10.  Inhibition by glucocorticoid and staurosporine of IL-4-dependent CD23 production in B lymphocytes is reversed on engaging CD40.

Authors:  A Katira; K A Knox; M Finney; R H Michell; M Wakelam; J Gordon
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.